Atlas Trials

Study Evaluating Patients With Cystinuria and Efficacy and Safety Exploratory Study in the Youngest Children

Clinical trial NCT04147871 · WITHDRAWN

Trial details

NCT number
NCT04147871
Sponsor
Advicenne Pharma
Status
WITHDRAWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Cystinuria
Start date
2024-03-01
Primary completion
2025-05-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.